Praveen Rajendran

Research Associate Professor

Texas A&M University Health Sciences Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Praveen Rajendran is a Research Associate Professor at Texas A&M University Health Sciences Center, USA. His research focuses on colorectal cancer, epigenetic regulation, and the development of tumor cultures for screening preventive agents. Recent publications highlight his work on alternative splicing, histone modification, and the interaction of dietary factors in precision oncology.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Roderick Dashwood

Director, Center for Epigenetics & Disease Prevention, Texas A&M Health and University Distinguished Professor, Department of Translational Medical Sciences, Texas A&M Medicine (Houston campus).

Texas A&M University

UNITED STATES

View details

Sultan Abda Neja

Texas A&M University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Praveen Rajendran

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Development of Primary Colon and Duodenal Tumor Cultures from the Apc-mutant Pirc Rat for Screening Preventive Agents

Alternative splicing of BAZ1A in colorectal cancer disrupts the DNA damage response and increases chemosensitization

A–Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer

Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors

Epigenetic regulation of major histocompatibility complexes in gastrointestinal malignancies and the potential for clinical interception

Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis

BRD9 Inhibition by Natural Polyphenols Targets DNA Damage/Repair and Apoptosis in Human Colon Cancer Cells

Optimization of erlotinib plus sulindac dosing regimens for intestinal cancer prevention in an Apc-mutant model of Familial Adenomatous Polyposis.

Targeting Epigenetic 'Readers' with Natural Compounds for Cancer Interception.

CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis.

Collaborators (2)

Roderick Dashwood

Sultan Abda Neja

Make your next move.